Laurus Labs peers

Companies like Laurus Labslatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

LAURUSLABS₹2,244.00

Laurus Labs Ltd.

· Pharma & Health
₹ CrorePeersDIVISLABGLANDMANKINDBIOCONALKEMLUPINFORTISGLENMARKMcap ₹1.21L Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
LAURUSLABS
FY26
DIVISLAB
FY26
GLAND
FY26
MANKIND
FY26
Peer
Average
Valuation — at last close
P/E136.25×99.89×◆ 49.31×53.28×67.49× +102%
P/B22.86×15.28×◆ 4.89×6.25×8.81× +159%
EV/EBITDA69.50×73.43×◆ 29.17×29.44×44.01× +58%
Market Cap₹1.21L Cr₹2.56L Cr₹50,655 Cr₹1.02L Cr₹1.36L Cr -11%
Growth
Revenue CAGR 3Y4.09%10.78%◆ 21.06%17.73%16.52% -75%
Revenue CAGR 5Y7.19%8.67%◆ 13.18%—10.93% -34%
Net Income CAGR 3Y3.91%12.09%9.57%◆ 13.96%11.87% -67%
Revenue YoY (latest Q)◆ 33.44%27.80%19.57%17.33%21.57% +55%
Net Income YoY (latest Q)◆ 124.27%65.50%47.09%37.67%50.09% +148%
Profitability
EBITDA Margin26.09%◆ 32.59%25.34%25.34%27.76% -6%
Net Income Margin13.07%◆ 24.32%15.98%13.57%17.96% -27%
Return on Common Equity◆ 18.19%16.19%10.53%12.49%13.07% +39%
Return on Capital Employed◆ 20.48%17.80%11.73%12.51%14.01% +46%
Return on Assets8.97%◆ 13.89%8.66%6.94%9.83% -9%
Credit & Quality
Total Debt/Equity0.44×◆ 0.00×0.02×0.38×0.13× +230%
Interest Coverage7.60×◆ 129.48×36.24×4.27×56.66× -87%
Scale — latest FY
Revenue / Total Income₹6,813 Cr₹10,560 Cr₹6,431 Cr₹14,278 Cr₹10,423 Cr -35%
Net Income₹890 Cr₹2,568 Cr₹1,027 Cr₹1,938 Cr₹1,844 Cr -52%
Total Assets₹10,511 Cr₹20,033 Cr₹12,511 Cr₹28,080 Cr₹20,208 Cr -48%
EPS₹16.47₹96.75₹62.35₹46.35₹68.48 -76%
Book Value per Share₹98.18₹632.49₹628.67₹394.87₹552.01 -82%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.